Filtros de búsqueda

Lista de obras de

A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study

artículo científico publicado en 2020

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS

scientific article published on 26 September 2019

Defining the clinical course of multiple sclerosis: the 2013 revisions

artículo científico publicado en 2014

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

artículo científico publicado en 2017

Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials

artículo científico publicado en 2018

Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents

scientific article published on 23 August 2018

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

artículo científico publicado en 2011

Molecular mechanism underlying the impact of vitamin D on disease activity of MS.

artículo científico publicado en 2014

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

artículo científico publicado en 2015

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

artículo científico

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

artículo científico publicado en 2013

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

artículo científico publicado en 2017

Vitamin D as an early predictor of multiple sclerosis activity and progression

artículo científico publicado en 2014

Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT

scientific article published on 16 April 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda